Rescue agents for treating botulinum toxin intoxications

Details for Australian Patent Application No. 2004291152 (hide)

Owner Allergan, Inc.

Inventors Li, Shengwen; Aoki, Kei Roger

Agent Davies Collison Cave

Pub. Number AU-A-2004291152

PCT Pub. Number WO2005/048949

Priority 10/715,810 17.11.03 US

Filing date 15 November 2004

Wipo publication date 2 June 2005

International Classifications

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/048949 Priority application(s): WO2005/048949

17 August 2006 Amendment Made

  The nature of the amendment is: Add co-inventor Francis, Joseph A and Steward, Lance E

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004291162-Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle

2004291149-Methods and Compositions for the Treatment of Metabolic Disorders